Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GAO Backs Prescription Pseudoephedrine Approach

This article was originally published in The Tan Sheet

Executive Summary

Senator Feinstein says PSE products should be available only by prescription nationwide. A GAO report supports “an expansion of prescription-only laws in the fight to combat the serious epidemic of meth production,” she says.

Advertisement

Related Content

Prescription PSE Law Would Cripple Sales, Push Costs – Industry Study
Prescription PSE Law Would Cripple Sales, Push Costs – Industry Study
NPLEx Pays Dividends In Stopping Multi-State PSE Purchases
Congress, Missouri Enhance Meth Enforcement

Topics

Advertisement
UsernamePublicRestriction

Register

PS106232

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel